QC Teamlead
Leading role in quality control and laboratory analysis
About Magle Biopolymers
Magle Biopolymers is part of the Magle Group – an international life science group with strong roots in dextran technology. We develop and manufacture advanced polymer-based materials used in medical products, contributing to improving patients’ lives.
As a CDMO entity within the group, Magle Biopolymers operates in a regulated environment with high quality requirements. Quality, accountability, and cross-functional collaboration are core elements of our daily work, and we continuously strive to improve our processes and solutions.
About the role
As QC Teamlead, you will hold a leading position within our QC team in Hårlev. You are responsible for managing and developing a team of five, as well as ensuring that quality work meets the expected standard. You have personnel responsibility and work closely with other departments, both on analytical tasks and documentation.
Role Responsibilities
· Lead and coach the QC team to ensure efficient and high-quality work.
· Conduct development discussions and follow up on performance.
· Plan and allocate tasks within laboratory analyses of raw materials, intermediates, finished products, and stability studies, as well as document-related tasks.
· Be responsible for accurate documentation and reporting of results in both digital and paper-based systems to ensure full traceability.
· Review and approve quality documents, such as SOPs, protocols, reports, and analytical methods, as well as handle change requests and deviations.
· Stay updated on current regulatory requirements and contribute to ensuring that operations adhere to applicable analytical standards (ISO, GMP).
· Drive improvement initiatives and develop laboratory processes for more efficient and precise analysis.
· Be responsible for the onboarding and development of team members.
Qualifications
· A university degree in analytical chemistry, biomedicine, or a related field.
· At least three years’ experience in a leadership role within quality control, preferably in the pharmaceutical or biotechnology sector.
· Proven experience with personnel responsibility and team leadership.
· Strong expertise in laboratory work, analytical methods, and quality documentation.
· Excellent proficiency in Danish and English, both spoken and written.
· Good computer skills and a willingness to learn new systems.
We offer
At Magle Biopolymers, you will join a highly skilled and dedicated team that values cooperation, creativity, quality, and accountability. We provide a stimulating work environment with substantial individual responsibility and opportunities for development in pharmaceutical analysis and quality control. Our organization is driven by values, and we seek individuals who share our ambition to make a difference for patients - by being innovative, motivated, positive, responsible, customer-focused, and a true team player. If you recognize yourself in this description and the role matches your experience, we look forward to hearing from you!
Application
We conduct interviews on an ongoing basis, so please submit your application as soon as possible.
We look forward to hearing from you!
If you have any questions regarding the role and QC, please reach out to our QA TL Gitte Jacobsen gitte.jacobsen@maglegroup.com
For HR-related questions, please contact HR Manager Rikke Tjustrup at rikke.tjustrup@maglegroup.com.
About Magle Group
Magle Group has a solid history within Life Science and has grown through strategic acquisitions. Today, the group consists of several specialized entities, including Magle Biopolymers, with a strong focus on dextran technology and CDMO services.
- Our organization
- Quality Control
- Locations
- Hårlev
- Employment type
- Full-time
Colleagues
About Magle Group
Magle AB (formed in 1995 as a pure development company) acquired Chemoswed AB (formed in 1944 as a manufacturing company) in 2016 before merging the companies in 2017 to form Magle Chemoswed. In 2019, Adroit Science AB was acquired to increase the development services segment. In 2021, PharmaCept GmbH was acquired as a first step to develop a sales and marketing organization for DSM products. In 2024 Magle Group welcomed Magle Biopolymers - a CDMO part of the group focusing on Dextran technology, and Magle BioPharma - a stem cell based CDMO.